A Randomized Comparison of a Biolimus-Eluting Stent With a Sirolimus-Eluting Stent for Percutaneous Coronary Intervention
Phase of Trial: Phase III
Latest Information Update: 01 Jun 2016
At a glance
- Drugs Umirolimus (Primary) ; Sirolimus
- Indications Acute coronary syndromes; Cardiovascular disorders; Coronary artery disease; Coronary artery restenosis; Myocardial infarction; Myocardial ischaemia
- Focus Registrational; Therapeutic Use
- Acronyms LEADERS
- Sponsors Biosensors International Group
- 21 May 2015 Results published in EuroPCR, as per Biosensors International Group media release.
- 23 Oct 2012 Five-year results presented at the 24th Annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, according to a Biosensors International Group media release.
- 27 Mar 2012 Pooled analysis presented at the 61st Annual Scientific Session of the American College of Cardiology.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History